1. Home
  2. GLAS vs FDMT Comparison

GLAS vs FDMT Comparison

Compare GLAS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glass House Brands Inc. Subordinate Voting Shares

GLAS

Glass House Brands Inc. Subordinate Voting Shares

N/A

Current Price

$7.85

Market Cap

836.9M

Sector

Health Care

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$15.10

Market Cap

695.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLAS
FDMT
Founded
N/A
2013
Country
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
836.9M
695.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
GLAS
FDMT
Price
$7.85
$15.10
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$31.71
AVG Volume (30 Days)
562.5K
741.5K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.79
EPS
N/A
N/A
Revenue
N/A
$85,209,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$70.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
230194.60
52 Week Low
$7.70
$6.96
52 Week High
$12.70
$16.93

Technical Indicators

Market Signals
Indicator
GLAS
FDMT
Relative Strength Index (RSI) 33.11 58.25
Support Level $7.70 $13.30
Resistance Level $8.41 $15.29
Average True Range (ATR) 0.42 0.83
MACD -0.02 -0.06
Stochastic Oscillator 14.89 72.64

Price Performance

Historical Comparison
GLAS
FDMT

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: